Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters

Bayraktaroglu T., Boztepe H., Kapran Y., Tanakol R., Alagoel F.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.118, no.8, pp.537-543, 2010 (SCI-Expanded) identifier identifier identifier


Context: The presence and the importance of FasL (FasL, APO-1L/CD95L) in papillary microcarcinoma lesions which are smaller than 1.5 cm of the thyroid is unclear.